Claims against Dr Reddy’s over Revlimid in US dismissed
On 22nd December, 2022 and 27th December, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Limited and Dr…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Celgene
Anti-trust litigation filed against Dr Reddy’s Laboratories and other generic pharma companies in US
The complaint seeks damages for purported overpayments and equitable relief
Dr Reddy’s announces settlement of Revlimid capsules patent litigation with Celgene in US
Celgene has agreed to provide Dr Reddy’s with a license to sell volume-limited amounts of generic lenalidomide capsules in the US…
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
37 M&A deals worth $18.9 bn in Aug 2019: GlobalData Report
Amgen’s proposed acquisition of Otezla from Celgene for $13.4 billion provides 71 per cent to deal value